CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Selvas AI Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Selvas AI Inc
401/402, 14F, Baeksang Star Twr 1 Cha
65, Digitalro 9-Gil
Phone: +82 28527788p:+82 28527788 SEOUL, 08594  South Korea Ticker: 108860108860

Business Summary
Selvas AI Inc is a Korea-based company engaged in the development and provision artificial intelligence (AI) related solutions. The Company operates its business through two segments. The Human Computer Interaction (HCI) segment mainly develops HCI technologies such as AI voice recognition, AI voice synthesis, AI handwriting intelligence, AI image intelligence and customized technologies. The AI Digital Transformation (AIDT) segment mainly engages in the digital transformation by utilizing HCI technologies on education-technology, healthcare, mobility, metaverse and non-fungible tokens (NFT) domains. The AIDT segment’s products including AI disease risk prediction product, smart fitness solution, digital textbook and mobile electronic dictionary. The Company also provides medical diagnostic equipment, assistant engineering, defibrillator and other medical equipment.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
12/31/202412/31/2024Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chief Executive Officer, Director Min CheolGwak 48 9/5/2019 12/30/2011
Assistant Managing Director Dong YilKim 42 3/29/2013 3/29/2013
Assistant Managing Director Jae WuKang 47
4 additional Officers and Directors records available in full report.

Business Names
Business Name
108860
HIMS International Corporation
JAWONMEDICAL. CO. LTD.

General Information
Number of Employees: 137 (As of 12/31/2015)
Outstanding Shares: 26,914,276 (As of 12/31/2024)
Shareholders: 80,654
Stock Exchange: KDQ
Fax Number: +82 226294586


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, March 28, 2025